HKU COVID-19 vaccine trials to start in July
Share - WeChat
A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- Emotional robot AIQ set to debut in China
- Huaihai fashion season ignites consumption vitality in Shanghai's iconic area
- Controversy erupts as Nanjing Museum's donated masterpiece surfaces at auction
- China's defense trade with Cambodia, Thailand unrelated to their border conflict: spokesman
- Over 3,400 foreign travelers utilize 240-hour visa-free policy to enter China through Xiamen
- China targets world-class Earth system forecasting network by 2035
































